Live Breaking News & Updates on Chengdu Origen

Stay updated with breaking news from Chengdu origen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2201 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

/PRNewswire/ Chengdu Origen Biotechnology Co., Ltd. ("Chengdu Origen") and Vanotech Ltd. ("Vanotech") announced today the first patient dosed in the. ....

United States , Avner Ingerman , Origen Vanotech , Vanotech Ltd , Prnewswire Chengdu Origen Biotechnology Co Ltd , Retina Research At Ophthalmic Consultants Of Boston , Vitreoretinal Service , Age Related Macular Degeneration , Chief Medical Officer , Retina Research , Ophthalmic Consultants , Chengdu Origen , Private Securities Litigation Reform Act , Vanotech Ltd ,